Skip to main content
. 2020 May 26;11:441. doi: 10.3389/fphys.2020.00441

FIGURE 4.

FIGURE 4

CXC chemokine ligand 9 (CXCL9) was targeted by miR-320a. (A) miRNAs in mesenchymal stem cell (MSC)-derived exosomes predicted in EVmiRNA database. (B) Upstream regulatory miRNAs of CXCL9 predicted in microRNA database and TargetScan database. (C) Luciferase activity of CXCL9-WT and CXCL9-MUT detected by dual luciferase reporter gene assay; the experiment was repeated three times independently. (D) MiR-320a mRNA level in synovial tissue of patients with osteoarthritis (OA) (n = 9) and patients with rheumatoid arthritis (RA) (n = 22) detected by RT-qPCR. (E) Pearson’s correlation analysis of expression of miR-320a and CXCL9 in synovial tissues of 22 patients with RA. Statistical analysis was performed using an independent sample t test. Data were expressed as mean ± standard deviation. *p < 0.05 compared with the treatment of mimic-NC group or OA patients.